K Watanabe

632 total citations
35 papers, 509 citations indexed

About

K Watanabe is a scholar working on Molecular Biology, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, K Watanabe has authored 35 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Epidemiology and 9 papers in Clinical Biochemistry. Recurrent topics in K Watanabe's work include Bacterial Identification and Susceptibility Testing (8 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). K Watanabe is often cited by papers focused on Bacterial Identification and Susceptibility Testing (8 papers), Clostridium difficile and Clostridium perfringens research (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). K Watanabe collaborates with scholars based in Japan, Thailand and United States. K Watanabe's co-authors include Keigo Ueno, Naoya Kato, Maki Itokazu, Nobuyuki Kato, Haru Kato, Yoshinori Muto, Hiroshi Ushijima, Shintaro Hashira, Naoki Katoh and Tetsuhiko Aoki and has published in prestigious journals such as The Astrophysical Journal, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

K Watanabe

33 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Watanabe Japan 14 142 137 90 77 74 35 509
S Ånséhn Sweden 14 210 1.5× 177 1.3× 162 1.8× 107 1.4× 83 1.1× 28 688
Setsuko Nishijima Japan 17 144 1.0× 289 2.1× 161 1.8× 42 0.5× 93 1.3× 51 806
Lucía Rossi Italy 11 70 0.5× 199 1.5× 154 1.7× 49 0.6× 56 0.8× 23 465
D K Giger United States 8 160 1.1× 213 1.6× 55 0.6× 130 1.7× 19 0.3× 10 504
Andrea Restrepo Colombia 13 162 1.1× 143 1.0× 104 1.2× 73 0.9× 80 1.1× 22 637
Hae Kyung Lee South Korea 13 119 0.8× 100 0.7× 103 1.1× 83 1.1× 39 0.5× 71 609
C.E. Walters United Kingdom 8 124 0.9× 151 1.1× 93 1.0× 65 0.8× 34 0.5× 12 553
Wolfgang Barousch Austria 9 215 1.5× 142 1.0× 67 0.7× 154 2.0× 56 0.8× 14 455
Marilena Galdiero Italy 16 151 1.1× 102 0.7× 226 2.5× 56 0.7× 48 0.6× 32 782
Johann Hausdorfer Austria 15 133 0.9× 167 1.2× 113 1.3× 185 2.4× 45 0.6× 20 588

Countries citing papers authored by K Watanabe

Since Specialization
Citations

This map shows the geographic impact of K Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Watanabe more than expected).

Fields of papers citing papers by K Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Watanabe. The network helps show where K Watanabe may publish in the future.

Co-authorship network of co-authors of K Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of K Watanabe. A scholar is included among the top collaborators of K Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Watanabe. K Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yamamoto, Yukinori, Makiko Fujii, K Watanabe, et al.. (2008). Effect of powder characteristics on oral tablet disintegration. International Journal of Pharmaceutics. 365(1-2). 116–120. 19 indexed citations
3.
Ito, Makoto, Jun Suzuki, Motoko Sasaki, et al.. (2006). Development of nonalcoholic steatohepatitis model through combination of high-fat diet and tetracycline with morbid obesity in mice. Hepatology Research. 34(2). 92–98. 25 indexed citations
4.
Katoh, Takayuki, et al.. (2003). Simple and rapid synthesis of siRNA derived from in vitro transcribed shRNA. Nucleic Acids Symposium Series. 3(1). 249–250. 11 indexed citations
5.
Mikamo, Hiroshige, Kyoko Kawazoe, Keisuke Izumi, et al.. (1998). Studies on the pathogenicity of anaerobes, especiallyPrevotella bivia, in a rat pyometra model. Infectious Diseases in Obstetrics and Gynecology. 6(2). 61–65. 28 indexed citations
6.
Itokazu, Maki, et al.. (1997). Antibiotic-loaded hydroxyapatite blocks in the treatment of experimental osteomyelitis in rats. Journal of Medical Microbiology. 46(9). 779–783. 38 indexed citations
7.
8.
Watanabe, K, et al.. (1997). In vitro activities of 10 antimicrobial agents against bacterial vaginosis-associated anaerobic isolates from pregnant Japanese and Thai women. Antimicrobial Agents and Chemotherapy. 41(10). 2297–2299. 13 indexed citations
9.
Kato, Naoki, et al.. (1996). Vaginal Microflora Associated with Bacterial Vaginosis in Japanese and Thai Pregnant Women. Clinical Infectious Diseases. 23(4). 748–752. 37 indexed citations
10.
Nonomura, Hideo, Nobuyuki Kato, Yutaka Ohno, et al.. (1996). Indigenous bacterial flora of medicinal leeches and their susceptibilities to 15 antimicrobial agents. Journal of Medical Microbiology. 45(6). 490–493. 28 indexed citations
11.
Matsumura, Hiroyoshi, et al.. (1996). Effective control of methicillin-resistant Staphylococcus aureus in a burn unit. Burns. 22(4). 283–286. 29 indexed citations
12.
Kondo, N, K Kasahara, T. KAMEYAMA, et al.. (1994). Intravenous Immunoglobulins Suppress Immunoglobulin Productions by Suppressing Ca2+ ‐Dependent Signal Transduction Through Fc γ Receptors in B Lymphocytes. Scandinavian Journal of Immunology. 40(1). 37–42. 32 indexed citations
13.
Watanabe, K, N Kondo, Osamu Fukutomi, et al.. (1994). Characterization of infiltrating CD4+ cells in atopic dermatitis using CD45R and CD29 monoclonal antibodies.. PubMed. 72(1). 39–44. 13 indexed citations
14.
Kato, Haru, J. J. Cavallaro, Nobuyuki Kato, et al.. (1993). Typing of Clostridium difficile by western immunoblotting with 10 different antisera. Journal of Clinical Microbiology. 31(2). 413–415. 16 indexed citations
15.
Kato, Naoya, et al.. (1993). In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria. Antimicrobial Agents and Chemotherapy. 37(5). 957–961. 9 indexed citations
16.
Watanabe, K, Keigo Ueno, Naoya Kato, et al.. (1992). In vitro susceptibility of clinical isolates ofBacteroides fragilis andBacteroides thetaiotaomicron in Japan. European Journal of Clinical Microbiology & Infectious Diseases. 11(11). 1069–1073. 7 indexed citations
17.
Watabe, J., Jun Mizutani, Haruo Suzuki, et al.. (1992). Short Communication: Effect of a Novel Parenteral Cephalosporin, E1077, on Normal Human Intestinal Microflora. Microbial Ecology in Health and Disease. 5(4). 1 indexed citations
18.
Watanabe, K, et al.. (1992). Immunosuppressive effect of bactobolamine.. PubMed. 24(4). 1368–71.
19.
Muto, Yoshinori, et al.. (1989). Macrolide accumulation by Bacteroides fragilis ATCC 25285. Antimicrobial Agents and Chemotherapy. 33(2). 242–244. 10 indexed citations
20.
Ft, Rapaport, et al.. (1976). Genetic studies of bone marrow transplantation in the canine species.. PubMed. 8(3). 423–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026